These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35771958)

  • 1. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia.
    Bahceci D; Alpert L; Storozuk T; Liao X; Yozu M; Westerhoff M; Kővári BP; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; ():. PubMed ID: 38907614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
    Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study.
    Choi WT; Yozu M; Miller GC; Shih AR; Kumarasinghe P; Misdraji J; Harpaz N; Lauwers GY
    Mod Pathol; 2020 May; 33(5):933-943. PubMed ID: 31822800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonconventional Dysplasia is Frequently Associated With Goblet Cell Deficient and Serrated Variants of Colonic Adenocarcinoma in Inflammatory Bowel Disease.
    Xiao A; Yozu M; Kővári BP; Yassan L; Liao X; Salomao M; Westerhoff M; Sejben A; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):691-698. PubMed ID: 38546105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
    Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist.
    Alipour Z; Stashek K
    J Clin Pathol; 2024 Jan; 77(2):77-81. PubMed ID: 37918911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
    Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
    Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Zhang R; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 May; ():. PubMed ID: 38809303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conventional and non-conventional dysplasia in patients with inflammatory bowel disease].
    Enea D; Lauwers G; Svrcek M
    Ann Pathol; 2023 Jun; 43(3):180-191. PubMed ID: 36906454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.